NASDAQ:MDWD
MediWound Ltd. Stock News
$18.24
+0.580 (+3.28%)
At Close: Apr 26, 2024
MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023
08:00am, Wednesday, 14'th Jun 2023
YAVNE, Israel, June 14, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today
MediWound: With Expenses Covered, Growth Is Within Reach
07:14pm, Wednesday, 31'st May 2023
MediWound, a company developing medical solutions for skin and burn conditions, is set to begin US distribution of its burn solution NexoBrid in Q3 2023. With a cash pile of over $57 million, the comp
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
09:25am, Tuesday, 30'th May 2023
MediWound (MDWD) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.84 per share a year ago.
MediWound to Report First Quarter 2023 Financial Results
08:00am, Friday, 12'th May 2023
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time
MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
08:00am, Wednesday, 26'th Apr 2023
Data to be highlighted in oral and poster presentations YAVNE, Israel, April 26, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-ge
MediWound Ltd. (MDWD) Q4 2022 Earnings Call Transcript
02:30pm, Thursday, 16'th Mar 2023
MediWound Ltd. (NASDAQ:MDWD ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors, IR Ofer Gonen - Chief Executive Officer Boaz Gur-Lavie -
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
09:56am, Thursday, 16'th Mar 2023
MediWound (MDWD) delivered earnings and revenue surprises of -521.05% and 56.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MediWound to Report Fourth Quarter and Year-End 2022 Financial Results
08:47am, Thursday, 02'nd Mar 2023
Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern Time
MediWound to Present Corporate Highlights at Upcoming Investor Conferences
08:00am, Thursday, 23'rd Feb 2023
YAVNE, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for
MediWound Ltd. (MDWD) Q3 2022 Earnings Call Transcript
12:30pm, Tuesday, 15'th Nov 2022
MediWound Ltd. (NASDAQ:MDWD ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Monique Kosse - MD, LifeSci Advisors Ofer Gonen - CEO Boaz Gur-Lavie - CFO Conference C
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates
09:47am, Tuesday, 15'th Nov 2022
MediWound (MDWD) delivered earnings and revenue surprises of -30% and 24.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
MediWound Ltd. (MDWD) CEO Ofer Gonen on Q2 2022 Results - Earnings Call Transcript
12:31am, Wednesday, 10'th Aug 2022
MediWound Ltd. (NASDAQ:MDWD ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Monique Kosse - Investor Relations Ofer Gonen - Chief Executive Officer Boaz Gur-Lavie - C
MediWound Schedules Second Quarter 2022 Financial Results
08:00am, Monday, 01'st Aug 2022
Conference Call and Webcast Scheduled for Tuesday, August 9, 2022 at 8:30 AM ET Conference Call and Webcast Scheduled for Tuesday, August 9, 2022 at 8:30 AM ET
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
12:15pm, Tuesday, 17'th May 2022 Zacks Investment Research
MediWound (MDWD) delivered earnings and revenue surprises of -9.09% and 1.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call Transcript
12:04pm, Tuesday, 17'th May 2022
MediWound Ltd. (NASDAQ:MDWD ) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Monique Kosse - IR Sharon Malka - CEO Boaz Gur-Lavie - Chief Financial Officer Ofer Gonen -
